7Baggers
 elevation oncology receives ftd from fda for eo-3021  TipRanks Sat, 15 Nov 2025 06:38:17 GMT

Elevation Oncology Inc
(NASDAQ:ELEV) 

ELEV stock logo

Elevation Oncology, Inc., an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. The company's lead candidate is EO-3021, an antibody-drug conjugate designed to target Claudin 18.2, a cl...

Founded: 2019
CEO / Founder: Shawn Leland 
Sector:
Industry:

Share this website to your friends